MedTrace Logo

Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot

NCT05045989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2021-09-22

No results posted yet for this study

Summary

Mixed-methods process evaluation of a residence-based asymptomatic SARS-CoV-2 testing participation pilot

Conditions

  • Covid19

Interventions

BEHAVIORAL

Residence-based testing participation pilot (SARS-CoV-2 testing with relaxed social distancing restrictions)

SARS-CoV-2 asymptomatic saliva testing (as available to all students at staff at the participating university) delivered with relaxed social distancing (behavioural element) in two halls of residence.

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Holly Blake, PhD · University of Nottingham

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05045989 on ClinicalTrials.gov